五洲新春（603667）(603667.SH)披露关于股票交易异常波动公告，公司控股股东之一致行动人浙江五 洲新春集团控股有限公司("五洲控股")于2025年11月3日～2025年12月29日完成减持公司股份999.98万 股，减持比例达2.73%，减持总金额4.81亿元。 ...

智通财经APP讯，弘业期货(03678)公布，公司控股股东的一致行动人苏豪弘业拟以集中竞价方式减持不 超过350万股，不超过弘业期货总股本的 0.3473%;苏豪汇鸿拟以集中竞价方式减持不超过657.77万股， 不超过弘业期货总股本的 0.6527%。两家股东合计以集中竞价方式减持不超过 1007.77万股，不超过弘 业期货总股本的 1%(若减持期间公司实施送股、 资本公积金转增股本、 配股等股权变动事项， 该股份 数量、 持股比例将相应进行调整。) 减持期间为自 2026 年 1 月 26 日起的 3 个月内进行，变动区间为 2026 年 1 月 26 日至 2026 年 4 月 25 日。 ...

紫光股份公告称，公司股东信达证券丰实2号单一资产管理计划于2025年12月11日-12月30日通过集中竞 价方式累计减持公司股份14,300,469股，占总股本的0.50%。持股数量由157,304,393股降至143,003,924 股，占比由5.50%降至4.999998%，不再是持股5%以上股东。此次减持符合前期计划，截至公告披露 日，减持计划尚未实施完毕，且不会导致公司控股股东及实控人变化。 ...

Group 1 - The core point of the news is that the controlling shareholder of Oulutong, Nanjing Wangyue Kewang Venture Capital Partnership, plans to reduce its stake by up to 2,100,000 shares, which is approximately 1.91% of the total share capital, through block trading within three months after the announcement [1] - The estimated cash proceeds from this reduction, based on the closing price of 232.90 yuan per share, would be around 489 million yuan [1] - Oulutong stated that this reduction will not lead to a change in the control of the listed company and will not affect the company's governance structure or ongoing operations [1] Group 2 - On September 26, Oulutong disclosed that the share reduction plan by its controlling shareholder and actual controller's concerted action partner, Taizhou Tongju Information Technology Consulting Partnership, was completed [2] - Taizhou Tongju reduced its stake by 1,900,000 shares at an average price of 182.02 yuan per share, resulting in cash proceeds of approximately 346 million yuan [2][3] - The actual controllers of Oulutong include Wang Heqiu, Wang Yulin, Wang Yuetian, Shang Yunsi, and Wang Yuefei, who collectively control 27.29% of the shares through various partnerships [3] Group 3 - A recent announcement indicated that Wang Yuetian plans to transfer 12.04775% of his shares in Wangyue Kewang to Shang Yunsi, which requires registration for changes in business registration [4] - An agreement was signed between Shang Yunsi and Wang Heqiu to act in concert for a period of 60 months regarding shareholder rights [4] - The market value of the transferred shares, based on the closing price on December 23, is approximately 401.5 million yuan [4] Group 4 - Oulutong's IPO raised a total of 931.293 million yuan, with a net amount of 849.0898 million yuan, exceeding the original plan by 29.51588 million yuan [5] - The funds raised are intended for projects including the expansion of power adapter production in Ganzhou, the establishment of a research and development center, and working capital [5] - The total issuance costs for Oulutong amounted to 82.2032 million yuan, with the lead underwriter receiving 65.1905 million yuan [6]

Summary of Key Points Core Viewpoint - Several companies are experiencing significant shareholder reductions, indicating potential shifts in ownership and investor sentiment within the market [1]. Shareholder Reductions - Euro Continental Holdings' controlling shareholder plans to reduce holdings by no more than 1.91% [1] - Bid Medicine's shareholders, including Li Yijing, plan to collectively reduce holdings by no more than 0.95% [1] - Zhanzi Island's shareholders and Island No. 1 Fund intend to reduce holdings by no more than 1% [1] - Qifan Cable's controlling shareholder and actual controller, Zhou Gonghua, has cumulatively reduced 0.74% of company shares [1] - Furan De's shareholder Renke Partnership has reduced a total of 9.8565 million shares [1] - Guoxin Technology's shareholder, Tibet Taida, has cumulatively reduced 1.73% of company shares [1] - Bid Medicine's shareholders, including Xinxin Management, Landan Management, and Wu Bo, have collectively reduced 1.12% of company shares [1] - Other notable reductions include: - Guangdong Financial Investment has cumulatively reduced 0.91% of Guanmeng High-tech shares [1] - UW Holdings Limited has cumulatively reduced 7.4673 million shares of United Water [1] - Zhongzheng Kaiyuan and Minquan Investment have collectively reduced 1.1092 million shares of Jiancheng Zuo Na [1] - Senior management of Baitong Energy, Liu Muliang, plans to reduce no more than 316,200 shares [1] - Junxing Wulian's shareholder Fengtuohui has reduced 667,000 shares [1] - Mingxin Xuteng's shareholder Zhuang Yan has reduced 1.00% of company shares [1] Other Notable Events - Ganfeng Lithium is under investigation for suspected insider trading, with the case transferred to the procuratorate for review and prosecution [1] - Delisting of Suwu Company has been announced, with the company's stock terminated and delisted [1]

Core Viewpoint - The company expressed confidence in its future development despite shareholder reductions due to personal financial needs [2] Group 1 - The reduction in shareholding by shareholders is based on their own financial requirements [2] - The management team remains optimistic about the company's future growth and performance [2] - The stock price in the secondary market is influenced by various factors including national macroeconomic policies, market conditions, and investor expectations [2] Group 2 - The management will continue to focus on operational management to achieve better performance and returns for shareholders [2]

诺普信公告称，公司实际控制人卢柏强及其一致行动人诺普信控股、润宝盈信、卢翠冬曾计划于2025年 9月9日公告披露之日起15个交易日后的三个月内，合计减持不超3000万股，即不超公司股份总数的 2.98%。截至公告日，上述股东通过集中竞价和大宗交易方式合计减持2919.99万股，占公司总股本的 2.91%。减持后，其合计持股比例从35.21%降至32.30%。本次减持计划实施完毕，不会导致实控人变 更，也不影响公司治理与经营。 ...

近日， 中国影视巨头华谊兄弟及其创始人深陷法律与财务漩涡。 据天眼查官网显示，近日华谊兄弟旗下两家核心公司华谊兄弟电影有限公司、华谊兄弟传媒股份有限公司及其法定代表人王忠磊、王忠军被 北京市朝阳区人民法院限制高消费，涉及7473万元执行案件。 | A | | | | | | | | | | 6 43-111 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 序号 案号 | | 限消令对象 | 限制法定代表人 | 申请人 | 涉案金额 (元) ② ÷ | 执行法院 | 立案日期÷ | 发布日期 ÷ | 原文 内容 | | | (2025)京0105执481 华谊兄弟电影有 | 13号 | 限公司 | 王母爱 | | | 北京市朝阳区人民 法院 | 2025-12-19 | | | | | 被执行人 ② | | | | | 2天眼查 | | --- | --- | --- | --- | --- | --- | | 被执行人 1 | | | | | 國 | | | 2 被执行总金额:7473.2128 万元 | | | ...

全新好公告称，持股5%以上股东建德隽林企业管理合伙企业（有限合伙）于2025年12月29日通过深交 所系统减持100股，占公司总股份0.000029%。本次权益变动后，其持有公司股票17,322,395股，占比 4.999998%，不再是持股5%以上股东。本次减持不涉及要约收购，不会导致控股股东和控制权变化。该 股东曾披露减持计划，不排除未来12个月继续减持可能。 ...

昭衍新药（603127）源(06127)发布公告，截至本公告披露日，北京昭衍新药研究中心股份有限公司(以 下简称"公司")实际控制人之一周志文持有公司股票74,725,981股，占公司总股本9.9704%，其持有的股 份来源于首发前限售股份及公司资本公积金转增股份等。周志文拟自本减持计划公告之日起15个交易日 后的3个月内通过上海证券交易所以集中竞价或大宗交易的方式减持不超过1498万股,不超过其持有股份 的20.0466%，不超过公司总股本的1.99873%。 ...